CCLF logo

CCLF Statement on Module 3 of the UK Covid-19 Inquiry

Focusing on the Future of Critical Care Across All Four Nations of the UK

The Critical Care Leadership Forum (CCLF) was established as a point of reference for accessing specialist advice for national policy initiatives, commissioning, research, audit, education, professional standards and clinical practice regarding the specialty of Intensive Care Medicine (also known as Critical Care). The primary role of the CCLF is to promote UK-wide high-quality care for patients with, or at risk, of critical illness through integrating the energies and skills of its participating organisations. The 27 organisations currently represented on the CCLF constitute the professional arm of UK critical care services and work collaboratively with specialist commissioning, clinical reference and other managerial boards of UK health services.

Module 3 of the UK Covid-19 Inquiry will shortly begin hearing evidence on the impact of Covid-19 on healthcare including a detailed analysis of the critical care response to the pandemic. Important lessons will be drawn not just on the Covid-19 response but on the future of UK intensive care services.

The CCLF believes that creating a sustainable future for intensive care services and the patients it treats is an important lesson from the Covid pandemic and for any future UK pandemic response.

We feel a focus on the following 3 areas is key:

1) Investment

1.1 In our workforce

The ambitions of the Long Term Workforce Plan (LTWP) for England need to be built on to deliver a resilient workforce capable of meeting the growing demands of the older, multimorbid population. Many of the points made in the plan apply equally to Scotland, Wales and Northern Ireland.

Investment in critical care should address:

  • Safe staffing levels in critical care as they are linked directly to patient safety. Levels are most under threat for registered nurses, medical staff, pharmacists and allied health professionals (AHPs) e.g. critical care dietitians. Many services are heavily reliant on internationally educated staff who need supportive immigration policies. The LTWP is entirely absent of detail on higher specialist training numbers; this is a critical issue for Intensive Care Medicine. The pre-Covid lack of specialist trained doctors in ICM has continued post-pandemic and must be addressed.
1.2 In our hospitals

Capital building projects have been paused or significantly amended as the economy across our nations has not been as strong as predicted. Consistent and sustained investment in the fabric of the NHS is required so that critical care units can deliver services in buildings appropriate to modern healthcare and respond safely to future pandemics without impacting on other services.

1.3 In our patients
  • Critical Care Outreach funding is not universal across the UK, and services are configured very differently.  Guaranteed funding, alongside a minimum Critical Care Outreach Team (CCOT) service specification, is needed to offer the reassurance and safeguards of Martha’s Rule/Call 4 Concern across the majority of UK hospitals that do not have funded 24-hour critical care outreach services.
  • Investment in our patients’ Post ICU Care. Community, peer-to-peer support and recovery services is needed. There are not enough resources to reach all post ICU patients to support their on-going recovery by way of mental health, community and recovery services. This means many patients return to hospital prematurely and do not recover with the ability to integrate back into family and working life and in turn, society.

2) Innovation

2.1 For service delivery

Intensive care medicine is a specialty dependent on technology for patient care. Investment in IT and equipment are fundamental to ensuring our staff can perform in their roles.

2.2 For service transformation
  • Intensive care services in smaller and more remote hospitals are under threat as they struggle to attract and retain staff, exacerbating inequalities of provision. Collaborative working across systems, funding of transfer services and adoption of new technologies can provide innovative solutions and remote support to these units.
  • Valuing our workforce by encouraging collaborative learning and working across our multidisciplinary teams, protecting and recognising the value of time for training and the role of educators.
  • The value of research was demonstrated in the rapidly improved intensive care survival rates during Covid. Dedicated support for staff to undertake research across the wider intensive care patient population would be of significant benefit to the critical care community and the patients we serve.

3) Addressing Inequality

3.1 In our patient population
  • Health outcomes are not equal across all sections of society with deprivation adversely affecting outcomes from intensive care e.g. drug deaths in Scotland are higher than in the rest of the UK. Addressing societal issues such as drug and alcohol misuse would improve health outcomes for those in poorer socioeconomic groups and relieve NHS pressure across all 4 nations.
3.2 In provision of intensive care beds

Covid highlighted the variation in provision of intensive care services across the UK e.g. there was no increase in staffed critical care bed capacity in Wales between 2010 and 2020. There needs to be greater focus on meeting this deficit directed at the areas of most need. An immediate commitment to achieving 10 intensive care beds per 100,000 population across the UK would be a tangible benefit to patients.

 

This statement is endorsed by the following CCLF members: